Literature DB >> 27657908

Rebuttal from Dr. Hofman and Dr. Ilié.

Marius Ilié1, Paul Hofman1.   

Abstract

Year:  2016        PMID: 27657908      PMCID: PMC5009090          DOI: 10.21037/tlcr.2016.08.05

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


× No keyword cloud information.
  4 in total

1.  Cancer biomarkers: Written in blood.

Authors:  Ed Yong
Journal:  Nature       Date:  2014-07-31       Impact factor: 49.962

Review 2.  Clinical Implications of Genomic Discoveries in Lung Cancer.

Authors:  Charles Swanton; Ramaswamy Govindan
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

3.  Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.

Authors:  Jean Sebastien Frenel; Suzanne Carreira; Jane Goodall; Desam Roda; Raquel Perez-Lopez; Nina Tunariu; Ruth Riisnaes; Susana Miranda; Ines Figueiredo; Daniel Nava-Rodrigues; Alan Smith; Christophe Leux; Isaac Garcia-Murillas; Roberta Ferraldeschi; David Lorente; Joaquin Mateo; Michael Ong; Timothy A Yap; Udai Banerji; Delila Gasi Tandefelt; Nick Turner; Gerhardt Attard; Johann S de Bono
Journal:  Clin Cancer Res       Date:  2015-06-17       Impact factor: 12.531

4.  Consensus on precision medicine for metastatic cancers: a report from the MAP conference.

Authors:  C Swanton; J-C Soria; A Bardelli; A Biankin; C Caldas; S Chandarlapaty; L de Koning; C Dive; J Feunteun; S-Y Leung; R Marais; E R Mardis; N McGranahan; G Middleton; S A Quezada; J Rodón; N Rosenfeld; C Sotiriou; F André
Journal:  Ann Oncol       Date:  2016-05-03       Impact factor: 32.976

  4 in total
  3 in total

1.  Commentary on tumor heterogeneity.

Authors:  Helmut H Popper
Journal:  Transl Lung Cancer Res       Date:  2016-08

Review 2.  Next-Generation Sequencing with Liquid Biopsies from Treatment-Naïve Non-Small Cell Lung Carcinoma Patients.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

Review 3.  Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice.

Authors:  Paul Hofman
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.